Amkor Technology
AMKR Nasdaq Semiconductors Financials FY2016βFY2025
Amkor Technology's revenue rose 6.2% to $6.7 billion in fiscal 2025. Its operating margin was 7.0%, about the same as 6.9% a year earlier. Free cash flow was $191 million, down 44.6%. It paid out $82 million in dividends and buybacks, 43% of free cash flow. The diluted share count rose 0.3%.
What Amkor Technology does
No business description yet.
- Legal name
- AMKOR TECHNOLOGY, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001047127-26-000014
0001047127
Revenue and margins
Amkor Technology had $6.7B of revenue in fiscal 2025, up 6.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $191M in fiscal 2025, 2.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amkor Technology returned $82.0M to shareholders in fiscal 2025, 43% of free cash flow. The diluted share count rose 0.3%.
Value Amkor Technology yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $560M and divides by 248.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.5x Β· peers 46.6x Β· sector 33.5x.
Balance sheet
Cash, debt and the ratios that show how comfortably Amkor Technology can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.1B | $1.2B | $1.6B | $1.6B | $2.0B |
| Debt incl. finance leases | $1.1B | $1.2B | $1.2B | $1.1B | $1.4B |
| Net debt / EBITDA | β0.0x | β0.0x | β0.4x | β0.5x | β0.5x |
| Debt / equity | 0.4x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 14.8x | 15.3x | 8.0x | 6.8x | 6.2x |
| Current ratio | 1.7x | 2.0x | 2.3x | 2.1x | 2.3x |
| Quick ratio | 1.4x | 1.6x | 2.0x | 1.9x | 2.0x |
| Total assets | $6.0B | $6.8B | $6.8B | $6.9B | $8.1B |
| Total liabilities | $3.1B | $3.1B | $2.8B | $2.8B | $3.6B |
| Shareholders' equity | $2.9B | $3.7B | $4.0B | $4.1B | $4.5B |
| Net debt (β = net cash) | β$9.0M | β$41.1M | β$417M | β$545M | β$560M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.9M
6 insiders
Of sales under plans
32%
$1.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Megan FaustCFO | Sold plan | 1,000 | $49.05 | $0.0M | Form 4 |
| Aug 17, 2026 | Mark N RogersEVP & General Counsel | Sold plan | 5,000 | $59.78 | $0.3M | Form 4 |
| Aug 11, 2026 | Megan FaustCFO | Sold plan | 1,000 | $54.45 | $0.1M | Form 4 |
| Aug 7, 2026 | Douglas A AlexanderDirector | Sold plan | 5,000 | $55.81 | $0.3M | Form 4 |
| Aug 6, 2026 | Guillaume Marie Jean RuttenDirector | Sold | 25,000 | $54.50 | $1.4M | Form 4 |
| Aug 5, 2026 | Guillaume Marie Jean RuttenDirector | Sold | 25,000 | $55.35 | $1.4M | Form 4 |
| Jul 30, 2026 | Kevin K. EngelPresident and CEO, Director | Sold | 3,221 | $47.00 | $0.2M | Form 4 |
| Jul 16, 2026 | Mark N RogersEVP & General Counsel | Sold plan | 5,000 | $65.12 | $0.3M | Form 4 |
| Jul 14, 2026 | Megan FaustCFO | Sold plan | 1,000 | $69.91 | $0.1M | Form 4 |
| Jun 16, 2026 | Mark N RogersEVP & General Counsel | Sold plan | 5,000 | $86.21 | $0.4M | Form 4 |
| Jun 12, 2026 | Winston J ChurchillDirector | Sold | 5,000 | $78.20 | $0.4M | Form 4 |
| Jun 9, 2026 | Megan FaustCFO | Sold plan | 1,000 | $70.30 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β13.4% | β10.7% | β9.6% |
| Altman Z'' | 4.77 | 4.64 | 4.49 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Amkor Technology AMKR | $9.8B | 6.2% | 7.0% | 2.9% | 10.4% | 22.5x | 6 | |
| GlobalFoundries GFS | $24.8B | 0.6% | 11.7% | 14.9% | 7.1% | β | 8 | Compare β |
| ON Semiconductor ON | $29.2B | β15.4% | 1.4% | 23.7% | 0.9% | 46.6x | 5 | Compare β |
| Marvell Technology MRVL | $210.5B | 42.1% | 16.1% | 17.0% | 7.0% | 75.4x | 6 | Compare β |
| First Solar FSLR | $18.5B | 24.1% | 30.6% | 22.8% | 22.7% | 10.6x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.9B | $4.2B | $4.3B | $4.1B | $5.1B | $6.1B | $7.1B | $6.5B | $6.3B | $6.7B |
| Gross profit | $710M | $761M | $711M | $649M | $901M | $1.2B | $1.3B | $943M | $933M | $939M |
| Research and development | $117M | $167M | $157M | $138M | $141M | $166M | $149M | $178M | $163M | $167M |
| Operating income | $309M | $406M | $258M | $233M | $457M | $763M | $897M | $470M | $439M | $467M |
| Interest expense | $79.7M | $83.8M | $78.9M | $66.0M | $64.2M | $51.5M | $58.6M | $59.0M | $64.9M | $75.4M |
| Pretax income | $230M | $308M | $186M | $160M | $387M | $715M | $857M | $444M | $431M | $445M |
| Income tax | $51.0M | $39.8M | $56.2M | $37.2M | $46.2M | $69.5M | $89.9M | $81.7M | $75.5M | $68.5M |
| Net income | $176M | $264M | $127M | $121M | $338M | $643M | $766M | $360M | $354M | $374M |
| Diluted EPS | $0.74 | $1.10 | $0.53 | $0.50 | $1.40 | $2.62 | $3.11 | $1.46 | $1.43 | $1.50 |
| Diluted shares | 0.24B | 0.24B | 0.24B | 0.24B | 0.24B | 0.25B | 0.25B | 0.25B | 0.25B | 0.25B |
| Cash flow | ||||||||||
| Cash from operations | $729M | $618M | $663M | $564M | $770M | $1.1B | $1.1B | $1.3B | $1.1B | $1.1B |
| Capital expenditure | $650M | $551M | $547M | $472M | $553M | $780M | $908M | $750M | $744M | $905M |
| Free cash flow | $79.4M | $67.3M | $116M | $91.4M | $217M | $342M | $190M | $521M | $345M | $191M |
| Depreciation and amortization | $555M | $582M | $572M | $524M | $510M | $564M | $613M | $632M | $595M | $642M |
| Stock-based compensation | $3.3M | $5.1M | $5.0M | $6.9M | $8.0M | $11.0M | $13.6M | $8.3M | $18.4M | $20.1M |
| Acquisitions | $0.0M | $43.8M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $51.2M | $55.1M | $74.7M | $179M | $81.9M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $51.2M | $55.1M | $74.7M | $179M | $82.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $550M | $596M | $682M | $901M | $832M | $1.1B | $1.2B | $1.6B | $1.6B | $2.0B |
| Total debt | $1.4B | $1.2B | $1.2B | $1.3B | $1.0B | $985M | $1.1B | $1.1B | $923M | $1.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $23.2M | $25.7M | $84.3M | $111M | $106M | $178M | $149M |
| Current assets | $1.4B | $1.6B | $1.7B | $2.0B | $2.1B | $2.9B | $3.3B | $3.2B | $3.1B | $3.9B |
| Current liabilities | $1.0B | $1.3B | $1.2B | $1.1B | $1.3B | $1.7B | $1.7B | $1.4B | $1.5B | $1.7B |
| Inventory | $268M | $214M | $231M | $221M | $297M | $485M | $630M | $393M | $311M | $438M |
| Property and equipment, net | $2.6B | $2.7B | $2.7B | $2.4B | $2.6B | $2.9B | $3.1B | $3.3B | $3.6B | $3.9B |
| Total assets | $4.1B | $4.5B | $4.5B | $4.7B | $5.0B | $6.0B | $6.8B | $6.8B | $6.9B | $8.1B |
| Total liabilities | $2.7B | $2.8B | $2.6B | $2.7B | $2.7B | $3.1B | $3.1B | $2.8B | $2.8B | $3.6B |
| Shareholders' equity | $1.4B | $1.7B | $1.8B | $2.0B | $2.3B | $2.9B | $3.7B | $4.0B | $4.1B | $4.5B |
| Margins | ||||||||||
| Gross margin | 18.1% | 18.1% | 16.5% | 16.0% | 17.8% | 20.0% | 18.8% | 14.5% | 14.8% | 14.0% |
| Operating margin | 7.9% | 9.6% | 6.0% | 5.8% | 9.1% | 12.4% | 12.7% | 7.2% | 6.9% | 7.0% |
| EBITDA margin | 22.0% | 23.5% | 19.2% | 18.7% | 19.2% | 21.6% | 21.3% | 16.9% | 16.4% | 16.5% |
| Net margin | 4.5% | 6.3% | 2.9% | 3.0% | 6.7% | 10.5% | 10.8% | 5.5% | 5.6% | 5.6% |
| FCF margin | 2.0% | 1.6% | 2.7% | 2.3% | 4.3% | 5.6% | 2.7% | 8.0% | 5.5% | 2.9% |
| Returns | ||||||||||
| Return on capital | 11.0% | 15.3% | 7.6% | 7.4% | 16.2% | 25.0% | 24.3% | 10.6% | 10.0% | 10.4% |
| Return on capital employed | 10.1% | 12.9% | 7.9% | 6.7% | 12.5% | 18.9% | 18.9% | 8.9% | 8.1% | 7.9% |
| Return on equity | 13.6% | 17.1% | 7.2% | 6.4% | 15.8% | 24.4% | 23.2% | 9.4% | 8.7% | 8.7% |
| Return on assets | 4.3% | 6.1% | 2.8% | 2.6% | 7.0% | 11.6% | 11.9% | 5.3% | 5.2% | 5.0% |
| Growth | ||||||||||
| Revenue growth | 36.2% | 7.1% | 2.6% | β6.1% | 24.6% | 21.5% | 15.5% | β8.3% | β2.9% | 6.2% |
| Net income growth | 243.5% | 50.2% | β51.8% | β4.9% | 179.7% | 90.2% | 19.1% | β53.0% | β1.6% | 5.6% |
| EPS growth | 236.4% | 48.7% | β51.8% | β5.7% | 180.0% | 87.1% | 18.7% | β53.1% | β2.1% | 4.9% |
| FCF growth | 68.9% | β15.2% | 72.7% | β21.4% | 137.4% | 57.4% | β44.2% | 173.3% | β33.7% | β44.7% |
| Share count change | 0.4% | 0.7% | 0.0% | 0.2% | 0.9% | 1.4% | 0.2% | 0.4% | 0.3% | 0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.9x | 0.7x | 0.7x | 0.6x | 0.2x | β0.0x | β0.0x | β0.4x | β0.5x | β0.5x |
| Debt / equity | 1.0x | 0.7x | 0.7x | 0.7x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 3.9x | 4.8x | 3.3x | 3.5x | 7.1x | 14.8x | 15.3x | 8.0x | 6.8x | 6.2x |
| Current ratio | 1.4x | 1.3x | 1.4x | 1.9x | 1.6x | 1.7x | 2.0x | 2.3x | 2.1x | 2.3x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.7x | 1.4x | 1.4x | 1.6x | 2.0x | 1.9x | 2.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 16.6% | 13.1% | 12.7% | 11.7% | 11.0% | 12.7% | 12.8% | 11.5% | 11.8% | 13.5% |
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.3% | 0.3% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 15.0% | 28.9% | 14.4% | 51.8% | 42.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 7.0 | 5.0 | 4.0 | 7.0 | 8.0 | 5.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 1.5 | 1.7 | 2.0 | 2.6 | 3.0 | 3.8 | 4.6 | 4.8 | 4.6 | 4.5 |
| Accruals ratio | β13.6% | β8.3% | β11.9% | β9.6% | β8.9% | β8.7% | β5.2% | β13.4% | β10.7% | β9.6% |
Source: SEC EDGAR XBRL filings (CIK 0001047127). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.